MYD88 L265P mutation and CDKN2A loss as early mutational events in primary central nervous system lymphomas.

e14041Background: The genetic alterations that define PCNSL are beginning to be identified, and the genomic evolution that conveys susceptibility or resistance to treatment in recurrent disease is ...